---
title: "SINOCHEM INTERNATIONAL: The bankruptcy reorganization application of its holding subsidiary Ningxia Lithium Battery has been accepted by the court"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263968906.md"
description: "Sinochem International's subsidiary Ningxia Lithium Battery has applied for bankruptcy reorganization, which has been accepted by the court, and a bankruptcy reorganization administrator has been appointed. Due to the impact of the external market environment, Ningxia Lithium Battery has been operating at a continuous loss and is insolvent. Sinochem International holds a 94% stake in it. As of September 30, 2025, Ningxia Lithium Battery's total assets amounted to 240.6297 million yuan, total liabilities were 286.7488 million yuan, and its revenue from January to September 2025 was 105.1354 million yuan, with a net profit of -23.5371 million yuan. The reorganization plan has not yet been determined, and the specific impact on profits and losses cannot be assessed"
datetime: "2025-11-03T08:46:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263968906.md)
  - [en](https://longbridge.com/en/news/263968906.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263968906.md)
generator: "portal-rs"
---

# SINOCHEM INTERNATIONAL: The bankruptcy reorganization application of its holding subsidiary Ningxia Lithium Battery has been accepted by the court

SINOCHEM INTERNATIONAL announced that its holding subsidiary Ningxia Lithium Battery recently received a "Civil Ruling" delivered by the Zhongwei Intermediate People's Court, which has ruled to accept the reorganization application of Ningxia Lithium Battery and appointed a bankruptcy reorganization administrator. Ningxia Lithium Battery has been continuously losing money and is insolvent due to external market conditions and other factors. SINOCHEM INTERNATIONAL holds a 94% stake in it. As of September 30, 2025, Ningxia Lithium Battery had total assets of 240.6297 million yuan and total liabilities of 286.7488 million yuan; from January to September 2025, it had revenue of 105.1354 million yuan and a net profit of -23.5371 million yuan. This reorganization may alleviate the company's operational burden, but since the plan has not been determined, the specific impact on the company's profits and losses cannot yet be assessed

### Related Stocks

- [600500.CN](https://longbridge.com/en/quote/600500.CN.md)

## Related News & Research

- [Does YZi Labs have a dream?](https://longbridge.com/en/news/297763553.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Denmark sends conscripts to Greenland as Arctic tensions grow](https://longbridge.com/en/news/297744144.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)
- [ZAWYA: Egypt establishes $100mln fund for water, dam projects in southern Nile Basin states](https://longbridge.com/en/news/297735027.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**